I work for a health insurance company and we had a conference call this week about the vaccines. Although these vaccines are the least studied in regards to long-term effects (months rather than years), the safety profile is really good. Most major complications that occur with vaccines occur in the 1st 8 weeks. Doesn’t mean that these vaccines won’t have issues, but already doing well in the first 2 months is extremely promising. With 11 million already known cases in the country, and likely 4-5 times that many who were asymptotic, there’s likely 50 million people already with immunity. Now start adding in 25 million people getting the vaccine monthly starting in December, we’re quickly going to turn the corner on this once we get past the holidays. The j&j and aztrozenica vaccines not likely to be released until maybe January, and they have a different mechanism of action compared to the Moderna/Pfizer versions. But all of them have had great success in targeting the “spike” protein on the virus, so luckily this virus can be handled with a vaccine compared to other viruses.